Related Experiment Video

Updated: Mar 28, 2026

Epigenetic Engineering of K562 Cells: Dual-Vector Episomal Strategy for Stable Targeted DNA Methylation using dCas9-DNMT3A and -HDAC1 Fusion Proteins
09:56

Epigenetic Engineering of K562 Cells: Dual-Vector Episomal Strategy for Stable Targeted DNA Methylation using dCas9-DNMT3A and -HDAC1 Fusion Proteins

Published on: October 31, 2025

595

Development of a Safeguard System Using an Episomal Mammalian Artificial Chromosome for Gene and Cell Therapy

Narumi Uno1,2, Katsuhiro Uno2, Shinya Komoto2

  • 1Chromosome Engineering Research Center, Tottori University, Yonago, Japan.

Molecular Therapy. Nucleic Acids
|December 17, 2015
PubMed

Insights

This study developed a novel safeguard system using an artificial chromosome to suppress transplanted cell tumors. This system leverages the host immune rejection of allogeneic tissue, enhancing stem cell therapy safety.

Area of Science:

  • Immunology
  • Genetics
  • Biotechnology

Background:

  • Clinical applications of stem cell therapy for intractable diseases require safeguard systems to eliminate tumorigenic cells.
  • Existing safeguard systems may disrupt the host genome or lack long-term stability.
  • A novel system is needed that is non-disruptive and stable for safe stem cell transplantation.

Purpose of the Study:

  • To develop a tumor-suppressing mammalian artificial chromosome with a safeguard system.
  • To utilize the host immune rejection system against allogeneic tissue for tumor suppression.
  • To validate the proof-of-concept for this safeguard system in a preclinical model.

Main Methods:

  • Constructed a mammalian artificial chromosome containing a safeguard system.
  • Introduced allogeneic major histocompatibility complex (MHC) class I (H2-K(d)) into B16F10 mouse melanoma cells.
  • Transplanted these modified cells into recipient C57BL/6J mice (MHC H2-K(b)) and assessed tumor growth.
  • Evaluated the effect of immunization with allogeneic splenocytes on tumor suppression.

Main Results:

  • B16F10 cells expressing allogeneic MHC H2-K(d) showed significantly decreased tumor volume in C57BL/6J mice (P < 0.01).
  • Tumor suppression was further enhanced by pre-immunization with MHC H2-K(d)-expressing splenocytes (P < 0.01).
  • The results demonstrate the efficacy of the allogeneic immune rejection-based safeguard system.

Conclusions:

  • The developed artificial chromosome safeguard system effectively suppresses tumor formation from transplanted cells.
  • This system holds promise for enhancing the safety of clinical stem cell applications.
  • Further research can explore its application in treating genetic disorders and other intractable diseases.

More Related Videos

Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors08:14

Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors

Published on: October 28, 2014

13.4K
Isolation, Culture, and Genetic Engineering of Mammalian Primary Pigment Epithelial Cells for Non-Viral Gene Therapy09:46

Isolation, Culture, and Genetic Engineering of Mammalian Primary Pigment Epithelial Cells for Non-Viral Gene Therapy

Published on: February 26, 2021

3.7K

Related Concept Videos

In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
17.6K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
28.1K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.3K